Optical Coherence Tomography And NEphropathy: The OCTANE Study

Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age18-80
SponsorUniversity of Edinburgh

About this trial

Patients with high blood pressure (hypertension) and chronic kidney disease are at an increased risk of developing heart disease and strokes. Part of this risk is due to changes in the structure and function of the blood vessels throughout the body. It is thought that reducing high blood pressure and treating chronic kidney disease improves the structure and function of blood vessels but information on this is limited. Optical coherence tomography (OCT) is a method of looking at the blood vessels at the back of the eye. It is a simple, quick and non-invasive test that you may have previously had during a visit to the optician. The purpose of the study is to ascertain whether OCT is able to detect changes in the eye's blood vessels in patients with hypertension and chronic kidney disease compared to healthy individuals and also to see if any differences seen improve with treatment.

Eligibility criteria

Qualifiers

Male or female

Age 18-80

Body mass index ≤35

For those with hypertension: BP ≥140/90 or on treatment for hypertension

Disqualifiers

Subject is below the age of legal consent, or is mentally or legally incapacitated

The subject has donated blood (450 ml) within the last 4 weeks

Past or present drug or alcohol abuse including intravenous drug abuse at any time

Participation in another clinical trial within 1 month

Trial design

Treatments tested in this trial

  • Not listed

Trial groups

150 Participants
are grouped into 5 trial groups

Sponsors and collaborators